4.5 Article Proceedings Paper

How bacteria and their products provide clues to vaccine and adjuvant development

Journal

VACCINE
Volume 24, Issue -, Pages S13-S19

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2005.01.104

Keywords

adjuvant; PAMP; TLR pathway; lipopolysaccharide; CpG

Funding

  1. Wellcome Trust Funding Source: Medline

Ask authors/readers for more resources

Evidence has emerged that both vertebrates and invertebrates share innate immune pathways involved in the recognition of and the response to micro-organisms, including bacteria and their products. As a consequence, particular degenerate products of bacteria can stimulate and modulate immune responses and influence acquired immunity and, potentially, protection against disease. New knowledge in this field is beginning, to explain how vaccine adjuvants work and will facilitate the future development of novel adjuvants and vaccines. (c) 2005 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available